Supplementary Table S2 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
Year: 2024
Type: supplementary-materials
Abstract: Supplementary Table S2
Authors: R. Leo Sakemura, Mehrdad Hefazi, Michelle J. Cox, Elizabeth L. Siegler, Sutapa Sinha, Michael J. Hansen, Carli M. Stewart, Jennifer M. Feigin, Claudia Manriquez Roman, Kendall J. Schick, Ismail Can, Erin E. Tapper, Paulina Horvei, Mohamad M. Adada, Evandro D. Bezerra, Lionel Aurelien. Kankeu Fonkoua, Michael W. Ruff, Cynthia L. Forsman, Wendy K. Nevala, Justin C. Boysen, Renee C. Tschumper, Cory L. Grand, Kamesh R. Kuchimanchi, Lars Mouritsen, Jason M. Foulks, Steven L. Warner, Timothy G. Call, Sameer A. Parikh, Wei Ding, Neil E. Kay, Saad S. Kenderian
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402806160